Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid
PHASE2
The primary objective of the study is to compare the effect of daily oral a...
A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment
N/A
This study will collect information from participants with Primary Biliary ...
Status
Recruiting
Location
Southern California Research Center
Start Date
2024-10-14
Trial ID
NCT06447168
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
PHASE3
The participants of this study will have confirmed Primary Biliary Cholangi...